DiaMedica Therapeutics Inc. (DMAC) Financials

$5.65

$0.43 (8.14%)
Last update: 11:10 AM EST
Day's range
$4.9
Day's range
$5.53
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25MEarning20182018201920192020202020212021202220222023202320242024-1145%-1145%-1145.5%-1145.5%-1146%-1146%-1146.5%-1146.5%-1147%-1147%-1147.5%-1147.5%-1148%-1148%Profit Margin
Profit Margin
Revenue
Earnings

DMAC Income statement / Annual

Last year (2024), DiaMedica Therapeutics Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, DiaMedica Therapeutics Inc.'s net income was -$24.44 M. See DiaMedica Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $500.00 K $0.00 $0.00 $0.00
Cost of Revenue $0.00 $30.00 K $25.00 K $24.00 K $21.00 K $21.00 K $0.00 $4.00 K $2.21 K $4.46 K
Gross Profit $0.00 -$30.00 K -$25.00 K -$24.00 K -$21.00 K -$21.00 K $500.00 K -$4.00 K -$2.21 K -$4.46 K
Gross Profit Ratio 0 0 0 0 0 0 1 0 0 0
Research and Development Expenses $19.06 M $13.11 M $7.84 M $8.77 M $8.31 M $7.90 M $4.52 M $3.21 M $1.76 M $886.07 K
General & Administrative Expenses $7.62 M $8.16 M $6.16 M $4.88 M $4.39 M $3.69 M $2.74 M $1.31 M $718.05 K $423.35 K
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $7.62 M $8.16 M $6.16 M $4.88 M $4.39 M $3.69 M $2.74 M $1.31 M $718.05 K $423.35 K
Other Expenses $0.00 $0.00 $0.00 $82.00 K -$205.00 K -$856.00 K -$68.00 K $6.00 K $0.00 $3.00 K
Operating Expenses $26.68 M $21.27 M $14.00 M $13.65 M $12.49 M $10.74 M $6.05 M $4.28 M $2.48 M $1.31 M
Cost And Expenses $0.00 $21.27 M $14.00 M $13.65 M $12.49 M $10.74 M $6.05 M $4.28 M $2.48 M $1.31 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.73 K $1.74 K
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $48.38 K $43.96 K
Depreciation & Amortization $0.00 $30.00 K $25.00 K $24.00 K $21.00 K $21.00 K $15.00 K $4.00 K $2.21 K $4.11 K
EBITDA -$24.38 M -$19.31 M -$13.98 M -$13.62 M -$12.24 M -$10.60 M -$5.64 M -$4.26 M -$2.15 M -$1.50 M
EBITDA Ratio 0 0 0 0 0 0 -11.28 0 0 0
Operating Income Ratio 0 0 0 0 0 0 -13.52 0 0 0
Total Other Income/Expenses Net $2.27 M $1.93 M $353.00 K $82.00 K $434.00 K $975.00 K $747.00 K $259.00 K $280.63 K -$104.38 K
Income Before Tax -$24.41 M -$19.34 M -$13.65 M -$13.56 M -$12.27 M -$10.62 M -$5.65 M -$4.26 M -$2.20 M -$1.43 M
Income Before Tax Ratio 0 0 0 0 0 0 -11.31 0 0 0
Income Tax Expense $30.00 K $43.00 K $28.00 K $28.00 K $27.00 K $31.00 K $80.00 K -$9.00 K $22.31 K $12.45 K
Net Income -$24.44 M -$19.38 M -$13.68 M -$13.59 M -$12.29 M -$10.65 M -$5.73 M -$4.26 M -$2.22 M -$1.44 M
Net Income Ratio 0 0 0 0 0 0 -11.47 0 0 0
EPS -0.6 -0.6 -0.52 -0.65 -0.78 -0.89 -0.74 -0.72 -0.47 -0.4
EPS Diluted -0.6 -0.6 -0.52 -0.65 -0.78 -0.89 -0.74 -0.72 -0.47 -0.4
Weighted Average Shares Out $40.40 M $32.57 M $26.44 M $20.77 M $15.68 M $11.99 M $7.74 M $5.94 M $4.74 M $3.62 M
Weighted Average Shares Out Diluted $40.40 M $32.57 M $26.44 M $20.77 M $15.68 M $11.99 M $7.74 M $5.94 M $4.74 M $3.62 M
Link